Docket Room.
HB 642·TX·house

Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

IntroducedFiled Nov 9, 2026
Sponsor: Venton Jones (D)
Latest Action

Filed

Nov 9, 2026

Email me when HB 642 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track HB 642. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

HB 642 proposes legislation concerning the prior‑authorization process for prescription‑drug benefits used to treat neurodegenerative conditions. It would apply to patients, health‑care providers and insurers that handle these medications. The measure aims to modify how such benefits are authorized, though the filing does not detail specific changes.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about HB 642

3 free questions a day, no account

Sponsors

  • Venton Jones (D) · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when HB 642 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HB 642 free

Or ask your AI assistant about HB 642 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice